How We Think - Physician

These are the posts from the How we think section that have been tagged with Physician.

To see all tags used in our posts, click here.

The role of brain health in treating MS

Anna Thomasson|7^th June 2019

Blue Latitude Health speaks to Professor Gavin Giovannoni, key opinion leader and Chair of Neurology, Barts and The London School of Medicine and Dentistry, about his theories on brain health, the importance of a holistic approach to MS and why digital technology is the future of effective MS care.

50 questions for delivering an exceptional healthcare brand experience

Zoe Bartley, Jenna Earl, Jiayi Chen|7^th March 2019

Our 50-question brand planning checklist for healthcare ensures you deliver an exceptional experience, based on what your stakeholders want and need

Q&A with Dr Timothy Vollmer, leading MS Neurologist

Blue Latitude Health|11^th December 2018

Blue Latitude Health sits down with key opinion leader and specialist neurologist Dr Timothy Vollmer to better understand the paradigm shift in MS treatment. He explains the challenges neurologists face when making treatment decisions, and why patients need to be treated with more efficacious drugs earlier on.

Navigating the antibiotic resistance crisis

Natasha Cowan|25^th October 2018

Blue Latitude Health speaks to Tara DeBoer, PhD, Postdoctoral Researcher and CEO of BioAmp Diagnostics to explore the antimicrobial resistance crisis, and learn how a simple tool could support physicians navigating this complex landscape.

The dark side of direct-to-consumer genetic tests

Natasha Cowan|28^th September 2018

Direct-to-consumer testing is an affordable way to better understand your DNA, but is this a leap forward in innovation or another layer clouding an already complex market? From anxious patients to unnecessary surgeries, we reveal the barriers for healthcare professionals and patients, and how to solve these industry challenges.

Mastering the precision medicine opportunity

David Cooney|16^th August 2018

The rise of precision medicine will transform the pharma business model, challenging the way we commercialise therapies. BLH Senior Consultant and precision medicine expert David Cooney, reveals how you can plan for this change.

Bringing the NHS into the 21st century

Dina Patel|27^th July 2018

As the NHS celebrates its 70th birthday and a £20bn “birthday gift” from the UK government, we find out how one company is delivering what the National Health Service really needs – a financially sustainable method of healthcare management. Dr Kruti Patel Clinical Operations Manager at virtual healthcare provider Medefer tells us more.

What do you do with your healthcare marketing data?

Natasha Cowan, Pany Koizi, Will Frostick, David Wood, Sarah White|9^th July 2018

Pharma marketers are now spending more on data analysis than ever before. However, many are struggling to see a return on investment. BLH sits down with four BOBI Analyst of the Year 2018 finalists to find out how they turn data into insights that make a real difference to the success of pharma brands.

Is the pharma business model ready for precision medicine?

Fred Bassett|11^th June 2018

Precision medicine promises to revolutionise patient outcomes and reduce costs for industry but is pharma ready for it? Blue Latitude Health Co-founder and Head of Strategy Fred Bassett explores the challenges and opportunities while introducing the latest issue of 'Perspective' magazine on this weighty topic.